Literature DB >> 28905012

A rare case, diagnosed as calcified callosal lipoma, when the patient presented with acute stroke.

Zeynep Özözen Ayas1, Dilcan Kotan2, Pınar Polat3.   

Abstract

Entities:  

Year:  2016        PMID: 28905012      PMCID: PMC5421519          DOI: 10.5114/amsad.2016.59586

Source DB:  PubMed          Journal:  Arch Med Sci Atheroscler Dis        ISSN: 2451-0629


× No keyword cloud information.
Intracranial lipomas are rare and generally located at pericallosal midline lesions. They are usually asymptomatic; when symptoms occur, they may depend on localization and include headache, seizure, psychomotor retardation, and cranial nerve deficits [1]. These mass lesions, which can be diagnosed with computed tomography (CT) or magnetic resonance imaging (MRI), cannot be treated with radical surgery, because they are usually adherent to the surrounding neurovascular structures and asymptomatic, and surgical excision may result in high mortality and morbidity risk. Incidental asymptomatic lipomas are not treated with surgical excision. However, surgery should be considered in the case of uncontrollable seizures, hydrocephalus, progressive dementia and increased intracranial pressure. In this article, we present a rare case of incidental pericallosal lipoma detected by neuroimaging at the time of consulting for acute cerebrovascular disease. A 47-year-old man presented to the emergency department with paresthesia in the right arm and leg for a day. His past medical history was notable for hypertension with a regular use of antihypertensive medications. His family history was not remarkable for any disorder. Neurological examination revealed minimal hemiparesia and hemihypoesthesia on the right side. Routine laboratory tests and electrocardiography were normal. Cranial CT revealed agenesis of the corpus and splenium of the corpus callosum as well as a lipoma located in the corpus callosum (Figure 1 A). Diffusion MRI and apparent coefficient (ADC) MRI and B100 sections also showed a subacute hemorrhagic infarction at the level of the left centrum semiovale, which extended to the external capsule (Figures 1 B–C). Contrast-enhanced brain MRI showed a non-contrast enhanced mass lesion consistent with lipoma that appeared hyperintense on T1 and FLAIR sequences and iso-hyperintense on T2 sequences (Figures 1 D–F). Imaging protocols performed for acute stroke and incidentally detected a pericallosal lipoma, which is a rare tumor. Echocardiography and carotid vertebral Doppler ultrasound examination performed for determination of the etiology of stroke were not remarkable for any pathology. He was asymptomatic, so surgical excision was not considered, and he was treated with oral antiaggregant therapy for stroke.
Figure 1

A – Cranial CT revealed agenesis of the corpus and splenium of corpus callosum as well as a lipoma located in corpus allosum as well as a lipoma located in corpus callosum. B, C – Diffusion MRI and apparent coefficient (ADC) MRI and B100 sections also showed a subacute hemorrhagic infarction at the level of left centrum semiovale, which extended to capsula externa. D–F – Contrast enhanced MRI showed a non-contrast enhanced mass lesion consistent with lipoma that appeared hyperintense on T1 and FLAIR sequences and iso-hyperintense on T2 sequences

A – Cranial CT revealed agenesis of the corpus and splenium of corpus callosum as well as a lipoma located in corpus allosum as well as a lipoma located in corpus callosum. B, C – Diffusion MRI and apparent coefficient (ADC) MRI and B100 sections also showed a subacute hemorrhagic infarction at the level of left centrum semiovale, which extended to capsula externa. D–F – Contrast enhanced MRI showed a non-contrast enhanced mass lesion consistent with lipoma that appeared hyperintense on T1 and FLAIR sequences and iso-hyperintense on T2 sequences Intracranial lipoma is a rare tumor, with a frequency of less than 0.1% among all intracranial tumors [2]. It usually derives from the pericallosal cistern and is designated as a corpus callosum lipoma. It is located in the interpeduncular, sylvian, superior cerebellar, quadrigeminal, and chiasmatic cistern; the cerebellopontine angle; and the internal auditory meatus or convexity. Despite having an unclear etiopathogenesis, it is considered as a congenital developmental malformed structure. One theory concerning its origin states that embryological primitive meninges originating from neural crest mesenchyma are converted into fatty tissue and differentiate into lipoma [3]. Since it originates from the meninges, intracranial lipoma is almost always located in the subarachnoid space. Wrongly differentiated subarachnoid space (lipoma) may cause cortical dysplasia by preventing the development of cortical tissue [4]. This embryogenic view of lesion pathogenesis explains the frequent association between this lesion and callosal and other brain hypoplasias. Intracranial lipomas are frequently accompanied by various central nerve system anomalies [2, 4]. The most frequent one among these is corpus callosum agenesis, while other anomalies include absent septum pellucidum, cranium bifidum, spina bifida, encephalocele, myelomeningocele, hypoplastic vermis, and cortical malformations [4]. Our case also had corpus callosum agenesis accompanying callosal lipoma. Intracranial lipoma is usually asymptomatic [1, 3]. Depending on its localization, cerebellopontine angle lipoma is the most symptomatic one, with a symptom frequency of 80%. In addition, callosal and sylvian fissure lipomas are symptomatic in 50% of cases, and quadrigeminal and ambient cistern lipomas in 20% of cases [1]. Infundibular and chiasmatic lipomas are frequently asymptomatic [1]. Symptomatic cases may occur with headache, dizziness, seizure, ataxia, visual disturbance, diplopia, impaired hearing, or hearing loss [5]. Güneyli et al. reported that only 16 of their 57 cases were symptomatic, of whom 9 patients had headache [6]. Our patient was asymptomatic and he was incidentally detected to have intracranial lipoma in imaging examinations performed for acute stroke. Initially diagnosed by autopsy series, intracranial lipomas have become more prevalent due to advances in CT and MR imaging. Lipomas appear as homogeneous, sharply circumscribed, hypodense, and non-contrast enhanced masses on CT [2]. On MRI, they appear hyperintense on T1 and FLAIR sequences, and hypo-isointense on T2 sequences, and they show no contrast enhancement [3]. Fat suppression technique may be applied for a detailed diagnosis, where they show signal loss. Intracranial lipomas may be confused with dermoid cysts, teratomas, and subacute hematoma on MRI [2, 7, 8]. While dermoid cysts and teratomas frequently have a heterogeneous signal density, lipomas appear homogeneous [1, 2]. On T2-weighted images of fast spin echo (FSE) lipomas appear hyperintense or hypointense, whereas they appear hyperintense on FLAIR images. Hyperintense appearance of lipomas on FSE T2-weighted and FLAIR sections may be confused with subacute hematoma. Our patient was diagnosed with a non-contrast enhanced pericallosal lipoma that appeared hyperintense on T1 and FLAIR sequences and iso-hyperintense on T2 sequences of MRI. In interhemispheric lipomas, particularly within the fibrous capsule covering the lipoma, calcifications are common [9]. These calcifications may appear as curvilinear lines, in a nodular pattern in the periphery or center of a lipoma. Güneyli et al. detected calcification in only 3 of 57 cases [6]. We observed linear calcifications in the periphery of the patient’s lipoma. The surgical treatment of lipoma is extremely difficult because they are adherent to surrounding tissues and they surround vessels and nerves [5, 7]. Surgical treatment should only be considered in the case of symptomatic progression, growth of mass, increased intracranial pressure, or hydrocephalus. We considered no surgical treatment for our patient since he was asymptomatic and had no compressive symptoms. Intracranial lipoma is a rare and usually asymptomatic lesion. Its diagnosis has become easier as a result of wider utilization of CT and MRI in neurology practice. It is important to diagnose these masses, which have mostly benign clinical features and may be encountered in clinical practice, and evaluate them, as their characteristics must be well known. In conclusion, this rare presentation of calcified pericallosal lipoma emphasized that is necessary to diagnose and differentiate acute stroke.
  7 in total

1.  Pathogenesis of intracranial lipoma: an MR study in 42 patients.

Authors:  C L Truwit; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  1990 Jul-Aug       Impact factor: 3.825

Review 2.  Cerebellopontine angle lipomas: report of four cases and review of the literature.

Authors:  Frédéric Tankéré; Elizabeth Vitte; Nadine Martin-Duverneuil; Jacques Soudant
Journal:  Neurosurgery       Date:  2002-03       Impact factor: 4.654

Review 3.  Intracranial lipoma of the sylvian fissure. Case report and review of the literature.

Authors:  R P Feldman; A Marcovici; P A LaSala
Journal:  J Neurosurg       Date:  2001-03       Impact factor: 5.115

4.  MRI findings in 32 consecutive lipomas using conventional and advanced sequences.

Authors:  R Bakshi; Z A Shaikh; S Kamran; P R Kinkel
Journal:  J Neuroimaging       Date:  1999-07       Impact factor: 2.486

5.  Intracranial lipomas. Diagnostic and therapeutic considerations.

Authors:  F Maiuri; S Cirillo; L Simonetti; M R De Simone; M Gangemi
Journal:  J Neurosurg Sci       Date:  1988 Oct-Dec       Impact factor: 2.279

6.  Intracranial lipoma. Diagnostic and therapeutic considerations.

Authors:  E Kazner; O Stochdorph; S Wende; T Grumme
Journal:  J Neurosurg       Date:  1980-02       Impact factor: 5.115

7.  Lipomas of the frontal lobe.

Authors:  H Sasaki; K Yoshida; H Wakamoto; M Otani; S Toya
Journal:  Clin Neurol Neurosurg       Date:  1996-02       Impact factor: 1.876

  7 in total
  1 in total

1.  Frontal subcutaneous lipoma associated with large interhemispheric lipoma and corpus callosum agenesis.

Authors:  Dhara Rana; Sayali Kulkarni; Jamshed Zuberi; Fred Berlin
Journal:  Radiol Case Rep       Date:  2021-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.